Related Experiment Video

Updated: Jun 4, 2026

Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells
09:26

Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells

Published on: February 20, 2015

Microparticles, malignancy and thrombosis

Sharon Zahra1, Julia A M Anderson, David Stirling

  • 1College of Medicine and Veterinary Medicine, University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, UK. zahrasharon@doctors.org.uk

British Journal of Haematology
|February 10, 2011
PubMed

Insights

Microparticles (MPs) are key players in health and disease, influencing blood clotting and cancer progression. Standardizing MP detection methods is crucial for future diagnostic and therapeutic applications.

Area of Science:

  • Biomedical research
  • Hematology
  • Oncology

Background:

  • Microparticles (MPs) are biological effectors in physiological and pathological processes.
  • MPs play roles in hemostasis, thrombosis, and cancer cell survival, invasiveness, and metastasis.
  • Elevated circulating MP levels and MP-dependent thrombogenic potential are reported in malignancy and thrombosis.

Purpose of the Study:

  • To highlight the significance of microparticles in various biological processes.
  • To address the challenges in microparticle research due to methodological inconsistencies.
  • To emphasize the future potential of microparticle assays in diagnostics and therapeutics.

Main Methods:

  • Review of existing literature on microparticle function and quantification.
  • Analysis of reported findings regarding MP levels in disease states.
  • Discussion of the impact of methodological standardization on research.

Main Results:

  • Microparticles are implicated in hemostasis, thrombosis, and cancer metastasis.
  • Increased circulating MPs are observed in patients with malignancy and thrombosis.
  • Current research is limited by a lack of standardized methods for MP identification and quantification.

Conclusions:

  • Standardization of methods is essential for advancing microparticle research.
  • Improved MP assays hold promise for future diagnostic and therapeutic applications.
  • Microparticles are significant biomarkers and therapeutic targets in various diseases.

More Related Videos

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)04:56

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

Isolation and Characterization of Microvesicles from Peripheral Blood06:03

Isolation and Characterization of Microvesicles from Peripheral Blood

Published on: January 6, 2017

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...